Guide · Published 26 October 2026

Peptide bioregulators (Cytomax, Cytogen, Khavinson peptides): what the evidence says

In short: Peptide bioregulators are capsules sold as “organ-specific” short peptides, developed by Vladimir Khavinson’s institute in St Petersburg: Cytomaxes are extracts of animal organs, Cytogens are synthetic. Most published research comes from that one group, in small studies, and we could not find independent trials of the capsules sold today. Claims that they restore or repair organs are not authorised health claims in the EU or GB. We could not find independent ISO 17025 lab reports, so we do not list them.

“Khavinson peptides”, “Cytomax” and “peptide bioregulators” are increasingly searched in Europe, often alongside claims that a capsule of short peptides can “restore” a specific organ.

This guide sets out what the products are, what we could and could not find in the research, how EU and GB rules treat their claims, and how we handle them on CleanAssay. All searches and pages were checked on 26 October 2026. There are no shop or affiliate links.

What they are

  • The St Petersburg Institute of Bioregulation and Gerontology, founded in 1992 and directed by Vladimir Khavinson, describes two product lines [1].
  • Cytomaxes: food supplements “based on peptide complexes isolated from animal organs and tissues”, sold as tablets and capsules [1].
  • Cytogens: short peptides made synthetically [1].
  • Each product is named after an organ or tissue, for example Cerluten (brain), Thyreogen (thyroid), Ventfort (blood vessels) or Svetinorm (liver). A manufacturer describes each as “aimed at supporting the functions of” that organ, states that they hold Russian state registration certificates as dietary supplements, and that they are “not intended to diagnose, treat, cure or prevent any disease” [2].
  • The institute’s theory is that these peptides act on gene expression and protein synthesis in the matching organ [1].

What the research shows (and what we could not find)

Volume, mostly from one group. PubMed lists about 490 records with V. Khavinson as an author [3]. A search for “peptide bioregulator(s)” returns about 106 records; about 67 of those do not list Khavinson as an author, but most are in Russian or Georgian journals and several include co-authors linked to the same institute [5].

Few controlled trials. Restricting Khavinson’s records to randomised controlled trials leaves 6 papers, published between 1999 and 2011, all co-authored by Khavinson [4]. They tested pineal, pituitary and thymus peptide preparations such as epithalamin, not the named capsules sold today.

The capsules themselves. For eight Cytomax product names (including Cerluten, Endoluten, Vladonix, Ventfort and Svetinorm) PubMed returned no records at all [6]. We could not find an independent, registered trial of any capsule sold today.

Getting through the gut. Peptides taken by mouth are largely broken down by digestion; for peptide medicines typically less than 1% reaches the blood intact, though some short peptides do better [7]. That does not rule out an effect, but it is why independent human trials of the actual capsules would matter.

What the rules say in the EU and GB

In the EU, any health claim on a food or food supplement must be authorised under Regulation (EC) No 1924/2006 [8]. The authorised list is in Regulation (EU) No 432/2012 [9]; Great Britain keeps its own register [10].

We could not find any authorised claim for peptide bioregulators, or any claim that a food “restores”, “rejuvenates” or “repairs” an organ. Wording like that cannot legally be used to sell a food supplement in the EU or GB.

Products made from animal organs also raise source-quality questions. Organs such as kidney and liver are where cadmium tends to accumulate in animals [11], so for an organ extract we would want to see batch-specific heavy-metal results, as well as species and country of origin.

Our stance

  • We could not find independent ISO 17025 lab reports for any peptide bioregulator product, so we do not list or link them.
  • If a brand publishes a batch-specific report from an accredited lab (identity, heavy metals and microbiology), we will review it against our COA checklist, the same as any other product.
  • We do not list or link injectable or “research use” peptides, and we do not plan to.
  • If you want an oral peptide product with independent lab reports, our collagen comparison shows the reports we could find. Note that collagen has no authorised EU or GB health claim either.

FAQ

What are Khavinson peptides?

Short peptides developed by Vladimir Khavinson’s St Petersburg institute and sold as “bioregulators”: Cytomaxes are extracts of animal organs, Cytogens are synthetic peptides. Each is marketed for a particular organ.

Is there good evidence that peptide bioregulators work?

Most published studies come from the developer’s own research group, are small and appear mainly in Russian-language journals. PubMed lists 6 randomised trials co-authored by Khavinson (1999–2011), none on the capsules sold today. We could not find independent replication.

Are peptide bioregulators legal in the EU and UK?

Health claims on food supplements must be authorised under Regulation (EC) No 1924/2006 in the EU, or on the GB NHC register. We could not find any authorised claim for these products, so claims that they repair or restore organs cannot be used to sell them.

Why doesn’t CleanAssay list Cytomax or Cytogen?

We could not find independent ISO 17025 lab reports for them. We will review any batch-specific accredited report a brand publishes.

Do peptides survive digestion?

Most are broken down in the stomach and small intestine. For peptide medicines taken by mouth, typically less than 1% reaches the blood intact, though this varies by peptide.

Related

Sources

  1. St Petersburg Institute of Bioregulation and Gerontology: institute brochure (describes Cytomaxes and Cytogens)
  2. Garmonia (manufacturer): “Cytomaxs” product overview page
  3. PubMed search: Khavinson V[Author] (about 490 records on 26 Oct 2026)
  4. PubMed search: Khavinson V[Author] AND randomized controlled trial[pt] (6 records, 1999–2011, on 26 Oct 2026)
  5. PubMed search: “peptide bioregulator(s)” (about 106 records on 26 Oct 2026)
  6. PubMed search: eight Cytomax product names (no records on 26 Oct 2026)
  7. Ali Hussein L, Nedic A, Sitovs A, Mohylyuk V. “Natural Oral Absorption of Therapeutic Peptides: Mechanisms and Physiological Determinants”. Pharmaceutics 2026;18:1091
  8. Regulation (EC) No 1924/2006 on nutrition and health claims made on foods
  9. Commission Regulation (EU) No 432/2012: list of permitted health claims made on foods
  10. Great Britain nutrition and health claims (NHC) register, GOV.UK
  11. Nordberg M, Nordberg GF. “Metallothionein and Cadmium Toxicology: Historical Review and Commentary”. Biomolecules 2022;12:360

Information only, not medical advice. This guide does not assess any individual seller and has no shop or affiliate links. Product names are used only to identify them.